Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Fosun Bids $584 Million for Portuguese Healthcare Chain

publication date: Sep 30, 2014
Demonstrating its continuing interest in healthcare assets, Fosun International raised its offer to acquire Espirito Santo Saude, a Portuguese chain of hospitals clinics and nursing homes, to $584 million, making Fosun the current high bidder. The takeover battle for ESS remains open, and ESS is trading slightly above Fosun's 4.82 euros per share offer. Today, in other news, Fosun and its partners announced they have closed the $434 million take-private acquisition of Chindex, a chain of private China hospitals and clinics. More details....

Stock Symbol: (HK: 656)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital